Skip to content
Study details
Enrolling now

The Long COVID-19 Wearable Device Trial

Scripps Translational Science Institute
NCT IDNCT05741112ClinicalTrials.gov data as of Apr 2026
Target enrollment

100,500

Study length

about 2 years

Ages

18+

Locations

1 site in CA

About this study

This trial is testing a wearable device to see if it can help manage symptoms of Long COVID-19 and post-exertional malaise. Participants will use the device, either one they already own or one provided by it, along with educational materials.

Based on ClinicalTrials.gov records.

What participants do

  • 1.Use Wearable device
Primary goalPrimary Objective 1:Assess the effect of study-provided devices and enhanced educational materials to manage Long COVID-19 symptom severity, compared to general educational materials alone using data from participants survey responses

Participation effort

Estimated from trial records. Details can vary by site.

Time + visits
Low3%
Logistics
Moderate50%

Logistics difficulty varies by site location and availability.

Trial highlights

Treatment details

Auto-extracted from trial records to preview treatments and outcomes.

Endpoints

Primary: Primary Objective 1:Assess the effect of study-provided devices and enhanced educational materials to manage Long COVID-19 symptom severity, compared to general educational materials alone using data from participants survey responses., Primary Objective 2: Collate a unique longitudinal dataset combining patients' demographics, symptoms, symptom severity, quality of life, and sensor data including sleep, activity, heart rate, heart rate variability, and Body Battery.

Secondary: Secondary Objective: Assess the longitudinal impact of sustained use of the study-provided devices and enhanced educational materials on symptom severity.

Body systems

Infectious